Research ArticleCancer

Immunotherapy of non-Hodgkin’s lymphoma with a defined ratio of CD8+ and CD4+ CD19-specific chimeric antigen receptor–modified T cells

See allHide authors and affiliations

Science Translational Medicine  07 Sep 2016:
Vol. 8, Issue 355, pp. 355ra116
DOI: 10.1126/scitranslmed.aaf8621
PDF Container

Stay Connected to Science Translational Medicine

Navigate This Article